Muface insurers cancel civil servant appointments after January

Muface crisis: Insurers cancel civil servant appointments

The agreement supporting healthcare for over one million Muface members expires on January 31, 2025. The three providers—DKV, Asisa, and Adeslas—are preparing to withdraw. Industry sources confirm that medical appointments scheduled after the expiration date are already being cancelled. CSIF reports that no new services are being accepted beyond this date. A paradox emerges: the public agency states in writing that users will retain "the same health and social benefits" under "identical conditions," while the companies paid to provide these services claim the opposite.

What is happening with Muface appointments?

Official narratives and ground realities diverge sharply. Muface insists internally that nothing will change when the agreement lapses. Adeslas, however, notified its members that "against our wishes, the terms offered in the next contract do not allow us to continue providing a sustainable, high-quality service to Muface." In essence, government funding does not cover the cost of serving this group.

Industry sources note the situation is not yet critical. With more than a month remaining before the deal ends, authorizations are rarely requested more than six weeks in advance. However, they acknowledge that appointments booked for February and March have already been cancelled. This quiet withdrawal began without press conferences or official statements.

CSIF, the leading union for this sector, states bluntly: "They are gambling with the peace of mind and health of our members." They have called for a demonstration in Madrid on December 14. Meanwhile, insurers shift responsibility: "Beyond January, it is up to Muface to guarantee the service."

Real costs: €1,300 per member versus €2,000 in public healthcare

This issue has moved from administrative dispute to financial reckoning. Data suggests subsidized costs per Muface user average around €1,300, compared to approximately €2,000 per user in the public system. While age and usage profiles differ, making direct comparison imperfect, the gap raises questions about efficiency.

Detailed breakdowns reveal surprising differentials. Some argue public healthcare costs at least double per user compared to the mutual insurance model, suggesting significant savings if generalized. Critics counter that the public system serves the entire population without age or income filters, making raw averages misleading.

Undisputed is that insurers have operated under agreements failing to cover costs for years. Now, they refuse to absorb further losses.

Why insurers are withdrawing now

The explanation lies in accounting rather than drama. Current contract terms are deemed unsustainable by companies due to an aging membership with above-average healthcare consumption and inadequate premiums. Adeslas cites corporate elegance; other sources state plainly: the business is unprofitable.

Some view Muface as a market distortion. Insurers previously accepted high-consumption clients at a loss because volume and brand visibility compensated. When volume ceases to offset losses and branding doesn't pay bills, incentives vanish. This coincides with the government preparing a new tender likely requiring higher subsidies.

Without an agreement, the antiestéticared scenario involves mass migration of members to public healthcare. Over a million people seeking slots in a system already facing waiting lists. The question isn't whether it can withstand pressure, but how quickly strain becomes visible.

Public healthcare burden: Who pays?

If the agreement collapses and members transfer to public care, impacts won't be uniform. Active civil servants and their beneficiaries have different consumption profiles than general retirees, yet both use a system operating at capacity limits. Saturation manifests in months-long waits for consultations or tests.

Responsibility remains unclear. Muface promises service continuity. Insurers defer to Muface. Unions accuse authorities of endangering health. The government hopes the new tender succeeds.

Time runs short. February and March appointments are disappearing. Members, long told there was no problem, now watch calendars nervously.

Privilege defended or questioned?

Underlying this debate is discomfort over whether civil servants should access publicly funded private healthcare while other workers cannot. Some argue eliminating Muface would equalize rights and end privilege. Others cite lower per-user costs compared to public systems.

The discussion conflates universal healthcare rights with management efficiency. One can defend public healthcare as a right while questioning its operational efficiency, or support Muface's model while acknowledging its limited accessibility.

Resolution requires funding, not communiqués. Money remains absent.

How long until the government offers terms insurers accept? And who bears political blame when members queue at public clinics?